Title:
ANTI-CANCER COMPOSITION COMPRISING ANTI-VSIG4 ANTIBODY
Document Type and Number:
WIPO Patent Application WO/2024/085726
Kind Code:
A1
Abstract:
The present invention relates to a composition for the prevention or treatment of cancer comprising a humanized anti-VISG4 antibody or an antigen-binding fragment thereof, and a composition further comprising an anti-PD-L1 antibody that exhibits a significant cancer prevention or treatment effect. The humanized anti-VISG4 antibody or binding fragment thereof of the present invention can exhibit an anti-cancer effect by regulating immune cells in the body and improving the micro-environment of cancer tissue, and when administered in combination with an anti-PD-L1 antibody, can exhibit a significant anti-cancer effect. Therefore, the present invention can be utilized in various fields of cancer prevention or treatment, especially in the prevention or treatment of cancer types that have a poor prognosis with respect to immune checkpoint inhibitor therapy.
Inventors:
KWON BYOUNG S (KR)
LEE JOONG WON (KR)
KIM HYE JEONG (KR)
KANG KYUNG JUNG (KR)
LEE JOONG WON (KR)
KIM HYE JEONG (KR)
KANG KYUNG JUNG (KR)
Application Number:
PCT/KR2023/016397
Publication Date:
April 25, 2024
Filing Date:
October 20, 2023
Export Citation:
Assignee:
EUTILEX CO LTD (KR)
International Classes:
C07K16/28; A61K39/00; A61P35/00
Attorney, Agent or Firm:
KAI INTERNATIONAL IP LAW FIRM (KR)
Download PDF: